Low diastolic blood pressure, hypoalbuminemia, and risk of death in a cohort of chronic hemodialysis patients

Kidney International

Volumn 51, Issue 4, 1997, Pages 1212-1217

  Iseki, Kunitoshi ^a   Miyasato, Fujihiko ^b   Tokuyama, Kiyoyuki ^b   Nishime, Keizo ^b   Uehara, Hajime ^b   Shiohira, Yoshiki ^b   Sunagawa, Hiroshi ^b   Yoshihara, Kunio ^b   Yoshi, Shinichiro ^b   Toma, Shigeki ^b   Kowatari, Teruo ^b   Wake, Toru ^b   Oura, Takashi ^b   Fukiyama, Koshiro ^b  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIASTOLIC BLOOD PRESSURE; FEMALE; HEMODIALYSIS; HUMAN; HYPOALBUMINEMIA; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 8244221005     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.165     Document Type: Article

References (40)

1. ISEKI K, KAWAZOE N, OSAWA A, FUKIYAMA K: Survival analysis of dialysis patients in Okinawa, Japan (1971-1990). Kidney Int 43:404-409, 1993
2. CHARRA B, CALEMARD E, RUFFET M, CHAZOT C, TERRAT JC, VANEL T, LAURENT G: Survival as an index of adequacy of dialysis. Kidney Int 41:1286-1291, 1992
3. CHARRA B, CALEMARD E, CUCHE M, LAURENT G: Control of hypertension and prolonged survival on maintenance hemodialysis. Nephron 33:96-99, 1983
4. ISEKI K, KAWAZOE N, FUKIYAMA K: Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int 44:115-119, 1993
5. LOWRIE EG, LEW NL: Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15:458-482, 1990
6. CHURCHILL DN, TAYLOR W, COOK RJ, LAPLANTE MMP, BARRE P, CARTIER P, FAY WP, GOLLDSTEIN MB, JINDAL K, MANDIN H, MCKENZIE JK, MURRHEAD N, PARFREY PS, POSEN GA, SLAUGHTER D, ULAN RA, WERB R: Canadian hemodialysis morbidity study. Am J Kidney Dis 19:214-234, 1992
7. COLLINS AC, HANSON G, UMEN A, KJELLSTRAND C, KESHAVIAH P: Changing risk factor demographics in end-stage renal disease patients entering hemodialysis and the impact on long-term mortality. Am J Kidney Dis 15:422-432, 1990
8. FLETCHER AE, BULPITT CJ: How far should blood pressure be lowered? N Engl J Med 326:251-254, 1992
9. LOWRIE EG, LAZARUS JM, HAMPERS CL, MERRILL JP: Cardiovascular disease in dialysis patients. N Engl J Med 290:737-738, 1974
10. FOLEY RN, PARFREY PS, HARNETT JD, KENT GM, MURRAY DC, BARRE PE: Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 49:1379-1385, 1996
11. MAILLOUX LU, BELLUCCI AG, WILKES BM, NAPOLITANO B, MOSSEY RT, LESSER M, BLUESTONE PA: Mortality in dialysis patients: Analysis of the causes of death. Am J Kidney Dis 18:326-335, 1991
12. CHEIGH JS, MILITE C, SULLIVAN JF, RUBIN AL, STENZEL KH: Hypertension is not adequately controlled in hemodialysis patients. Am J Kidney Dis 19:453-459, 1992
13. VERTES V, CANGIANO JL, BERMAN LB, GOULD A: Hypertension in end-stage renal disease. N Engl J Med 280:978-981, 1969
14. WOLCOTT DL, MAIDA CA, DIAMOND R, NISSENSON AR: Treatment compliance in end-stage renal disease patients on dialysis. Am J Nephrol 6:329-338, 1986
15. LARAGH JH, PICKERING TG: Essential hypertension, in The Kidney (4th ed), edited by BRENNER BM, RECTOR FC, New York, W.B. Sauders 1991, pp 1909-1939
16. SCHALEKAMP MA, BEEVERS DG, BRIGGS JD, BROWN JJ, DAVIES DL, FRASER R, LEBEL M, LEVER AF, MEDINA A, MORTON JJ, ROBERTSON JIS, TREE M: Hypertension in chronic renal failure. An abnormal relation between sodium and the renin-angiotensin system. Am J Med 55:379-390, 1973
17. ACOSTA JH: Hypertension in chronic renal disease. Nephrology Forum. Kidney Int 22:702-712, 1982
18. ZUCCALA A, SANTORO A, FERRARI G, ZUCCHELLI P: Pathogenesis of hypertension in hemodialysis patients: A pharmacological study. Kidney Int 34(Suppl 25):S190-S191, 1988
19. TAGUCHI J, FRIES ED: Partial reduction of blood pressure and prevention of complications in hypertension. N Engl J Med 291:329-331, 1974
20. HARDY R, HAWKINS CM: The impact of selected indices of antihypertensive treatment on all-case mortality. Am J Epidemiol 117:566-574, 1983
21. RUTAN GH, KULLER LH, NEATON JD, WENTWORTH DN, MCDONALD RH, SMITH WM: Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention trial. Circulation 77:504-514, 1988
22. ERROA M, GOLDWASSER P, COLLIER JT, MITTMAN N, AVRAM MM: Prealbumin and mortality risk in hemodialysis (HD). (abstract) J Am Soc Nephrol 3:364, 1992
23. DEGOULET P, LEGRAIN M, REACH I, AIME F, DEVRIES C, ROJAS P, JACOBS C: Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study. Nephron 31:103-110, 1982
24. ACCHIARDO SR, MOORE LW, LATOUR PA: Malnutrition as the main factor in morbidity and mortality of hemodialysis patients. Kidney Int 24(Suppl 16):S199-S203, 1983
25. ISEKI K, UEHARA H, NISHIME K, TOKUYAMA K, YOSHIHARA K, KINJO K, SHIOHIRA Y, FUKIYAMA K: Impact of the initial levels of laboratory variables on survival in chronic dialysis patients. Am J Kidney Dis 28:541-548, 1996
26. VINCENTI F, AMEND WJ, ABELE J, FEDUSKA NJ, SALVATIERRA O: The role of hypertension in hemodialysis-associated atherosclerosis. Am J Med 68:363-369, 1980
27. LINDNER A, CHARRA B, SHERRARD D, SCRIBNER B: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290:697-701, 1974
28. ROSTAND SG, GRETES JC, KIRK KA, RUTSKY EA, ANDREOLI TE: Ischemic heart disease in patients with uremia undergoing maintenance hemodialysis. Kidney Int 16:600-611, 1979
29. TOZAWA M, ISEKI K, FUKIYAMA K: Hypertension in dialysis patients: A cross-sectional analysis. Jpn J Nephrol 38:129-135, 1996
30. OLIVER WJ, COHEN EL, NEEL JV: Blood pressure, sodium intake, and sodium related hormones in the Yanomamo indians, a "No-salt" culture. Circulation 52:146-151, 1975
31. GOLPER TA, BENNETT WM: Use of drugs in renal failure, in Textbook of Nephrology (2nd ed), edited by MASSRY SG, GLASSOCK RJ, New York, Williams & Wilkins, 1989, pp 1447-1458
32. CUTLER RE, FORLAND SC, HAMMOND PGSTJ: Pharmacokinetics of drugs and the effects of renal failure, in Textbook of Nephrology (2nd ed), edited by MASSRY SG, GLASSOCK RJ, New York, Williams & Wilkins, 1989, pp 1434-1447
33. BRUNET PH, JABER K, BERLAND Y, BAZ M: Anaphylactoid reactions during hemodialysis and hemofiltration: Role of associating AN 69 membrane and angiotensin 1-converting enzyme inhibitors. Am J Kidney Dis 19:444-447, 1992
34. ESCHBACH JW, EGRIE J, DOWNING M, BROWNE J, ADAMSON J: Correction of anemia of end-stage renal disease with recombinant human erythropoictin. N Engl J Med 316:73-78, 1987
35. WOLFE RA, STRAWDERMAN RL: Logical and statistical fallacies in the use of Cox regression models. Am J Kidney Dis 27:124-129, 1996
36. PARFREY PS, FOLEY RN, HARNETT JD, KENT GM, MURRAY D, BARRE PE: Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int 49:1428-1434, 1996
37. ISEKI K, KINJO K, KIMURA Y, OSAWA A, FUKIYAMA K: Evidence for high risk of cerebral hemorrhage in chronic dialysis patients. Kidney Int 44:1086-1090, 1993
38. ISEKI K, FUKIYAMA K: Predictors of stroke in patients receiving chronic hemodialysis. Kidney Int 50:1672-1675, 1996
39. ELIAHOU HE, IAINA A, REISIN E, SHAPIRA J: Probability of survival in hypertensive and nonhypertensive patients on maintenance hemodialysis. Israel J Med Sci 13:33-38, 1977
40. CHESTER AC, SCHREINER GE: Hypertension and hemodialysis. Trans Am Soc Artif Internal Organs 24:36-42, 1978